Abstract
The effects of dipyridamole on red cell filterability both in vitro and ex vivo were measured. In a balanced, randomised and double-blind trial, six healthy male and female volunteers (22-37 years) were given dipyridamole 400 mg/day or matching placebo in four divided doses for 3 days, and heparinised venous blood samples were taken 1 h after the ingestion of the last dose. Filterability of red cells was increased significantly (P less than 0.05 paired t-test) when the subjects were on dipyridamole compared with placebo. In separate experiments, 15 min incubation with 2 or 20 micrograms/ml dipyridamole in vitro was found to have no effect on the filterability of freshly prepared red cell suspensions. After 24 h storage at 4 degrees C, the filterability of red cells was significantly decreased (P less than 0.01) and this could be partially prevented by adding dipyridamole to the stored cells (P less than 0.05). These results suggest that dipyridamole has an effect on the behaviour of the red cell membrane to increase the deformability of the cells. This may contribute to its therapeutic effect.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gibson J. G., 2nd, Lionetti F. J. The effect of dipyridamole on the adenosine triphosphate level of stored human blood. Transfusion. 1966 Sep-Oct;6(5):427–437. doi: 10.1111/j.1537-2995.1966.tb04758.x. [DOI] [PubMed] [Google Scholar]
- Gorman R. R., Bunting S., Miller O. V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins. 1977 Mar;13(3):377–388. doi: 10.1016/0090-6980(77)90018-1. [DOI] [PubMed] [Google Scholar]
- Masotti G., Poggesi L., Galanti G., Neri Serneri G. G. Stimulation of prostacyclin by dipyridamole. Lancet. 1979 Jun 30;1(8131):1412–1412. doi: 10.1016/s0140-6736(79)92053-1. [DOI] [PubMed] [Google Scholar]
- Mills D. C., Smith J. B. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J. 1971 Jan;121(2):185–196. doi: 10.1042/bj1210185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moncada S., Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet. 1978 Jun 17;1(8077):1286–1289. doi: 10.1016/s0140-6736(78)91269-2. [DOI] [PubMed] [Google Scholar]
- Wiley J. S., McCulloch K. E., Bowden D. S. Increased calcium permeability of cold-stored erythrocytes. Blood. 1982 Jul;60(1):92–98. [PubMed] [Google Scholar]
- Yawata Y., Jacob H. S., Matsumoto N., White J. A possible role for cyclic nucleotides in the regulation of erythrocyte shape and permeability. J Lab Clin Med. 1976 Oct;88(4):555–562. [PubMed] [Google Scholar]
- Zachara B. The effect of persantin on the phosphate compounds in erythrocytes during blood conservation. Acta Haematol. 1972;48(3):164–175. doi: 10.1159/000208453. [DOI] [PubMed] [Google Scholar]